Havana, January 9 (RHC)-- Cuba's BioCubaFarma Group has projected more than 40 research studies throughout 2017, using human subjects.
In statements to the press, Orlando Perdomo, Director of the Havana-based Center for Medical Research and Development, said the planned projects will involve different entities attached to BioCubaFarma group in the fields of chemistry, drugs and molecular immunology. He pointed to research and development of new generic medication, natural products, which contribute significantly to traditional treatments of several diseases.
The BioCubaFarma official added that there is also an investment plan aimed at increasing production capacity six-fold, including the construction of a new plant at the Mariel Special Development Zone, located in the western Cuban province of Artemisa.
Cuba's BioCubaFarma Group Projects New Scientific Research in 2017
Related Articles
Commentaries
MAKE A COMMENT
All fields requiredMore Views
- Statement by the Minister of Foreign Affairs of the Republic of Cuba, Bruno Rodríguez Parrilla, at the quarterly open debate of the UN Security Council on The situation in the Middle East, including the Palestinian Question
- An agreement with major social implications
- Argentina’s president fires his foreign minister after vote in favor of ending U.S. blockade against Cuba
- Overwhelming victory at United Nations: Cuba supported by 187 votes against the blockade; two in favor of maintaining the genocidal measures
- Venezuelan president reveals María Corina Machado is between Panama and Colombia asking for new sanctions